PULMONX CORP (LUNG) Stock Income Statement
NASDAQ:LUNG - Nasdaq - US7458481014 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 83.79M | 68.67M | 53.66M | 48.42M | 32.73M | |||
| Cost Of Goods | 21.79M | 17.92M | 13.80M | 12.79M | 11.53M | |||
| Gross Profit | 62.00M | 50.75M | 39.87M | 35.63M | 21.20M | |||
| Operating Expenses | 118.00M | 112.69M | 98.50M | 82.93M | 53.54M | |||
| Research and Development | 15.87M | 18.08M | 15.40M | 13.06M | 7.46M | |||
| Selling, General, and Administrative Expenses | 102.03M | 94.61M | 83.11M | 69.87M | 46.07M | |||
| Operating Income | -56.00M | -61.94M | -58.64M | -47.30M | -32.33M | |||
| Interest Income/Expense | 1.65M | 1.54M | 60.00K | -1.03M | -2.87M | |||
| Other Income/Expense | 156.00K | 127.00K | 0.00 | 20.00K | 3.18M | |||
| Non Recurring Items | -1.70M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -55.89M | -60.27M | -58.57M | -48.32M | -32.02M | |||
| Income Tax | 500.00K | 571.00K | 350.00K | 340.00K | 210.00K | |||
| Net Income | -56.39M | -60.84M | -58.92M | -48.66M | -32.23M | |||
| EBITDA | -54.51M | -60.39M | -57.13M | -46.43M | -31.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.44 | -1.60 | -1.59 | -1.35 | -0.90 | |||
| Non GAAP EPS | -1.40 | -1.60 | -1.59 | -1.31 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 74.00% | 73.90% | 74.30% | 73.59% | 64.77% | |||
| Profit Margin | -67.30% | -88.60% | -109.80% | -100.50% | -98.47% | |||
| Operating Profit Margin | -66.84% | -90.19% | -109.28% | -97.69% | -98.78% | |||
All data in USD